Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Soureti, S. Vakali, A. Florou, D. Michailidis, K. Triviza, C. Roussos, C. Gratziou (Athens, Greece). Withdrawal symptoms in psychiatric patients treated with varenicline. Eur Respir J 2008; 32: Suppl. 52, 2075

Member's Comments

No comment yet.

Related content which might interest you: Influence of psychiatric disorders in patients treated with Varenicline. Source: International Congress 2017 – Smoking cessation treatment and e-cigarettes Year: 2017 The effects of anxiety and depression on treatment adherence in COPD patients Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Problems of treatment of TB patients suffering from alcohol and drugs addiction Source: Eur Respir J 2002; 20: Suppl. 38, 369s Year: 2002 Effects of CPAP treatment on anxiety and depression in patients with OSAS Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Depressive symptoms in asthma patients Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Enough is enough: misuse of NIV in the treatment of chronic patients with exacerbation of symptoms? Source: Annual Congress 2013 –The dark side of the moon: when, why, and where I should not use NIV? Year: 2013 Attitudes of patients with chronic breathlessness towards treatment with opioids Source: Eur Respir J, 55 (2) 1901752; 10.1183/13993003.01752-2019 Year: 2020 Acute psychosis after CPAP treatment in a schizophrenic patient with sleep apnoea{-}hypopnoea syndrome Source: Eur Respir J 2001; 17: 313-315 Year: 2001 Impact of add-on medications on patient‘s satisfaction in patients with asthma Source: Eur Respir J 2005; 26: Suppl. 49, 273s Year: 2005 High prevalence of current smokers among COPD patients with anxiety and depression symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 193s Year: 2001 Prevalence of psychiatric disorders in seriously-ill COPD patients Source: Annual Congress 2008 - COPD epidemiology Year: 2008 The efficacy and side-effects of varenicline in patients with pneumologic diseases Source: Annual Congress 2009 - Smoking cessation Year: 2009 Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Nurse-led cognitive behavioural therapy for treatment of anxiety in COPD Source: ERJ Open Res, 4 (4) 00221-2018; 10.1183/23120541.00221-2018 Year: 2018 Patients with moderate asthma symptoms may benefit from short-term inhaled corticosteroid monotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 615s Year: 2007 Opioid prescription for severe chronic breathlessness to hospitalised patients with COPD - a clinical audit Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 GERD and anxiety in patients with severe COPD Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Withdrawal of ICS in patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone Source: Eur Respir J 2013; 42: 394-403 Year: 2013